These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6168106)

  • 1. [Importance of serum alpha-fetoprotein follow-up analysis in chronic liver diseases].
    Frysák Z; Hauftová D; Fingerová H
    Vnitr Lek; 1981 Jun; 27(6):611-5. PubMed ID: 6168106
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum alpha-fetoprotein in chronic liver disease.
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha 1 fetoprotein-determiantion in patients with liver diseases].
    Lamerz R; Schmalhorst U; Grunst J
    Z Gastroenterol Verh; 1976; (11):49-53. PubMed ID: 65863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum alpha-1 fetoprotein in chronic liver diseases].
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Orv Hetil; 1982 Aug; 123(34):2091-7. PubMed ID: 6182517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum alpha fetoprotein concentration in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1979 Jul; 120(28):1677-80. PubMed ID: 89652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic importance of alpha fetoproteins in oncology].
    Grob PJ; Dati F; Joller-Jemelka HI
    Ric Clin Lab; 1983; 13 Suppl 2():77-97. PubMed ID: 6199828
    [No Abstract]   [Full Text] [Related]  

  • 7. [Follow-up analysis of persistent low positive serum alpha-fetoprotein (AFP)--report on 420 cases].
    Zhang BC
    Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):26-8. PubMed ID: 2579782
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated alpha-fetoprotein in association with loss of serum HBeAg.
    McDonnell WM; Lucey MR
    Am J Gastroenterol; 1993 Sep; 88(9):1441-3. PubMed ID: 7689785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of carcinoembryonic antigen and alpha fetoprotein in liver diseases].
    Hasik J; Klincewicz H; Majewski P; Witkowski J; Breborowicz J
    Pol Tyg Lek; 1978 Jul; 33(30):1165-8. PubMed ID: 80796
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas.
    Boman F; Bossard C; Fabre M; Diab N; Bonnevalle M; Boccon-Gibod L
    Eur J Pediatr Surg; 2004 Feb; 14(1):63-6. PubMed ID: 15024683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal-predominant mesenchymal hamartoma of the liver with elevated serum alpha-fetoprotein level.
    Gunes D; Uysal KM; Cecen E; Cakmakci H; Ozer E; Akgur FM; Olgun N
    Pediatr Hematol Oncol; 2008 Sep; 25(7):685-92. PubMed ID: 18850482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of patients with chronic liver disease for hepatocellular carcinoma by ultrasonography.
    Okazaki N; Yoshida T; Yoshino M; Matue H
    Clin Oncol; 1984 Sep; 10(3):241-6. PubMed ID: 6206972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
    Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
    Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins].
    Aoyagi Y; Ichida F
    Rinsho Byori; 1983 Dec; 31(12):1286-93. PubMed ID: 6202901
    [No Abstract]   [Full Text] [Related]  

  • 15. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
    Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
    Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor markers in focal and diffuse liver diseases].
    Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
    Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R; Runge M; Stieber P; Meissner E
    Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.